missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human DHTKD1 (aa 106-181) Control Fragment Recombinant Protein
Click to view available options
Quantity:
100 μL
Unit Size:
100µL
Description
Highest antigen sequence indentity to the following orthologs: Mouse (84%), Rat (84%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-84706 (PA5-84706. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
The 2-oxoglutarate dehydrogenase complex catalyzes the overall conversion of 2-oxoglutarate to succinyl-CoA and CO(2). It contains multiple copies of three enzymatic components: 2-oxoglutarate dehydrogenase (E1), dihydrolipoamide succinyltransferase (E2) and lipoamide dehydrogenase (E3).
Specifications
Specifications
| Accession Number | Q96HY7 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 55526 |
| Name | Human DHTKD1 (aa 106-181) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | AMOXAD; C330018I04Rik; CMT2Q; dehydrogenase E1 and transketolase domain containing 1; dehydrogenase E1 and transketolase domain-containing protein 1; Dhtkd1; DKFZp762M115; KIAA1630; MGC3090; Probable 2-oxoglutarate dehydrogenase E1 component DHKTD1, mitochondrial |
| Common Name | DHTKD1 |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction